Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Advanced Health Intelligence (ASX:AHI) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Advanced Health Intelligence's EV-to-EBIT for today is
Advanced Health Intelligence's current Enterprise Value is A$19.73 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Advanced Health Intelligence's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was A$-7.49 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Advanced Health Intelligence's EV-to-EBITDA for today is:
Advanced Health Intelligence's current Enterprise Value is A$19.73 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Advanced Health Intelligence's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was A$-7.31 Mil.
Advanced Health Intelligence's current Enterprise Value is A$19.73 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Advanced Health Intelligence's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was A$0.12 Mil.
Advanced Health Intelligence's current Enterprise Value is A$19.73 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Advanced Health Intelligence's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2024 was A$-3.36 Mil.
Advanced Health Intelligence's current Enterprise Value is A$19.73 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Advanced Health Intelligence's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was A$-3.36 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Advanced Health Intelligence Enterprise Value Related Terms
Advanced Health Intelligence Enterprise Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Advanced Health Intelligence Enterprise Value Chart
ASX:AHI vs PRST, LAAB, VRTC: Enterprise Value Comparison
For the Software - Application subindustry, Advanced Health Intelligence's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Advanced Health Intelligence Enterprise Value vs Software Industry
For the Software industry and Technology sector, Advanced Health Intelligence's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Advanced Health Intelligence's Enterprise Value falls into.
Advanced Health Intelligence Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Advanced Health Intelligence (ASX:AHI) has a Enterprise Value of A$19.73 Mil as of Jun. 29, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Advanced Health Intelligence and its competitors.
Is Advanced Health Intelligence's Enterprise Value too high?
Advanced Health Intelligence's current Enterprise Value is A$19.73 Mil.
How does Advanced Health Intelligence's Enterprise Value compare to PRST and LAAB?
Advanced Health Intelligence's Enterprise Value of A$19.73 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Software company?
A good Enterprise Value depends on the Software industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Advanced Health Intelligence and its competitors. Advanced Health Intelligence's current Enterprise Value is A$19.73 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced Health Intelligence stock overvalued right now?
Advanced Health Intelligence (ASX:AHI) has a current Enterprise Value of A$19.73 Mil. The current Enterprise Value is A$19.73 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Advanced Health Intelligence (ASX:AHI), the current Enterprise Value is A$19.73 Mil as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Advanced Health Intelligence Ltd (AHI) is engaged in developing and delivering user-friendly biometric scans to render vital signs and health risk estimates to a smartphone. By leveraging the smartphone with purpose-built computer vision, machine learning models, and patented algorithms, AHI provides a private and secure way for individuals to perform biometric health-risk assessment and stratification. AHI's technology delivers simple-to-use, scalable, and cost-effective means to enable individuals to check, track and act towards better health outcomes. The combination of the patented and proprietary BodyScan dimensioning and composition capabilities and, FaceScan to return vital signs enables a unique health assessment capability made accessible anytime, anywhere through the smartphone.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:AHI has been successfully added to your 